LSTA Annual CAPEX
N/A
31 December 2023
Summary:
LSTA annual capital expenditures is not available.LSTA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Quarterly CAPEX
N/A
30 September 2024
Summary:
LSTA quarterly capital expenditures is not available.LSTA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA TTM CAPEX
N/A
30 September 2024
Summary:
LSTA TTM capital expenditures is not available.LSTA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
LSTA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Lisata Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $1.04 M(+70.7%) | $3.89 M(+22.0%) |
| Dec 2015 | $3.19 M(-12.9%) | $612.00 K(-20.6%) | $3.19 M(-3.6%) |
| Sept 2015 | - | $771.20 K(-47.1%) | $3.31 M(+9.4%) |
| June 2015 | - | $1.46 M(+323.3%) | $3.02 M(+9.4%) |
| Mar 2015 | - | $344.50 K(-52.9%) | $2.76 M(-24.5%) |
| Dec 2014 | $3.66 M(+35.9%) | $731.40 K(+50.3%) | $3.66 M(-21.7%) |
| Sept 2014 | - | $486.70 K(-59.4%) | $4.67 M(-4.0%) |
| June 2014 | - | $1.20 M(-3.2%) | $4.86 M(+25.4%) |
| Mar 2014 | - | $1.24 M(-28.9%) | $3.88 M(+44.1%) |
| Dec 2013 | $2.69 M(+406.6%) | $1.74 M(+156.3%) | $2.69 M(+109.9%) |
| Sept 2013 | - | $680.10 K(+216.3%) | $1.28 M(+105.5%) |
| June 2013 | - | $215.00 K(+301.1%) | $623.90 K(+37.8%) |
| Mar 2013 | - | $53.60 K(-83.9%) | $452.90 K(-14.8%) |
| Dec 2012 | $531.30 K(-7.6%) | $333.70 K(+1444.9%) | $531.30 K(+100.0%) |
| Sept 2012 | - | $21.60 K(-50.9%) | $265.70 K(-26.8%) |
| June 2012 | - | $44.00 K(-66.7%) | $363.00 K(<-9900.0%) |
| Mar 2012 | - | $132.00 K(+93.8%) | -$300.00(-100.1%) |
| Dec 2011 | $574.90 K(-96.5%) | $68.10 K(-42.7%) | $574.90 K(-86.9%) |
| Sept 2011 | - | $118.90 K(-137.2%) | $4.37 M(-46.2%) |
| June 2011 | - | -$319.30 K(-145.1%) | $8.13 M(-39.0%) |
| Mar 2011 | - | $707.20 K(-81.7%) | $13.32 M(-18.7%) |
| Dec 2010 | $16.38 M(+585.9%) | $3.87 M(-0.2%) | $16.38 M(+15.3%) |
| Sept 2010 | - | $3.88 M(-20.4%) | $14.21 M(+29.9%) |
| June 2010 | - | $4.87 M(+29.4%) | $10.94 M(+78.0%) |
| Mar 2010 | - | $3.76 M(+121.9%) | $6.15 M(+157.4%) |
| Dec 2009 | $2.39 M | $1.70 M(+178.1%) | $2.39 M(+244.3%) |
| Sept 2009 | - | $610.00 K(+710.1%) | $693.50 K(+684.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | $75.30 K(+1221.1%) | $88.40 K(+574.8%) |
| Mar 2009 | - | $5700.00(+128.0%) | $13.10 K(+33.7%) |
| Dec 2008 | $9800.00(-91.7%) | $2500.00(-49.0%) | $9800.00(-83.2%) |
| Sept 2008 | - | $4900.00(>+9900.0%) | $58.50 K(-42.1%) |
| June 2008 | - | $0.00(-100.0%) | $101.10 K(-7.8%) |
| Mar 2008 | - | $2400.00(-95.3%) | $109.60 K(-7.0%) |
| Dec 2007 | $117.90 K(+173.5%) | $51.20 K(+7.8%) | $117.90 K(+21.8%) |
| Sept 2007 | - | $47.50 K(+458.8%) | $96.80 K(+55.1%) |
| June 2007 | - | $8500.00(-20.6%) | $62.40 K(+15.8%) |
| Mar 2007 | - | $10.70 K(-64.5%) | $53.90 K(+24.8%) |
| Dec 2006 | $43.10 K(+1206.1%) | $30.10 K(+129.8%) | $43.20 K(+229.8%) |
| Sept 2006 | - | $13.10 K(-2283.3%) | $13.10 K(+297.0%) |
| Dec 2004 | $3300.00(+26.9%) | -$600.00(-200.0%) | $3300.00(-15.4%) |
| Sept 2004 | - | $600.00(-72.7%) | $3900.00(+18.2%) |
| June 2004 | - | $2200.00(+100.0%) | $3300.00(+6.5%) |
| Mar 2004 | - | $1100.00(>+9900.0%) | $3100.00(+19.2%) |
| Dec 2003 | $2600.00(+136.4%) | $0.00(0.0%) | $2600.00(0.0%) |
| Sept 2003 | - | $0.00(-100.0%) | $2600.00(0.0%) |
| June 2003 | - | $2000.00(+233.3%) | $2600.00(-100.2%) |
| Mar 2003 | - | $600.00(>+9900.0%) | -$1.25 M(<-9900.0%) |
| Dec 2002 | $1100.00(-87.9%) | $0.00(0.0%) | $1100.00(0.0%) |
| Sept 2002 | - | $0.00(-100.0%) | $1100.00(0.0%) |
| June 2002 | - | -$1.25 M(-199.9%) | $1100.00(-99.9%) |
| Mar 2002 | - | $1.25 M(+6662.7%) | $1.25 M(+4864.7%) |
| Dec 2001 | $9100.00(-64.0%) | - | - |
| Dec 2000 | $25.30 K(-94.6%) | $18.50 K(+176.1%) | $25.20 K(+276.1%) |
| Sept 2000 | - | $6700.00 | $6700.00 |
| Dec 1999 | $464.40 K | - | - |
FAQ
- What is the all time high annual CAPEX for Lisata Therapeutics?
- What is the all time high quarterly CAPEX for Lisata Therapeutics?
- What is the all time high TTM CAPEX for Lisata Therapeutics?
What is the all time high annual CAPEX for Lisata Therapeutics?
Lisata Therapeutics all-time high annual capital expenditures is $16.38 M
What is the all time high quarterly CAPEX for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly capital expenditures is $4.87 M
What is the all time high TTM CAPEX for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM capital expenditures is $16.38 M